OpenURL Connection Search

Select item for more details and to access through your institution.

A 1-year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal-bolus insulin therapy (Kumamoto Insulin Degludec Observational study).
Published in:
Journal of Diabetes Investigation, 2016, v. 7, n. 5, p. 703, doi. 10.1111/jdi.12496
By:
- Shimoda, Seiya;
- Sato, Miki;
- Sekigami, Taiji;
- Motoshima, Hiroyuki;
- Yoshimura, Ryohei;
- Fukuda, Kazuki;
- Matsuo, Yasuto;
- Noda, Hideyuki;
- Okubo, Mina;
- Ichimori, Shinji;
- Fujisawa, Kazuo;
- Fukunaga, Makiko;
- Araki, Eiichi;
- Nishikawa, Takeshi;
- Furukawa, Noboru;
- Matsumura, Takeshi;
- Kondo, Tatsuya;
- Kawashima, Junji;
- Senokuchi, Takafumi;
- Igata, Motoyuki
Publication type:
Article
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites result in impaired function at different steps of IRS-1 signaling.
Published in:
1997
By:
- Yoshimura, Ryohei;
- Araki, Eiichi;
- Ura, Sachiko;
- Todaka, Mikio;
- Tsuruzoe, Kaku;
- Furukawa, Noboru;
- Motoshima, Hiroyuki;
- Yoshizato, Kazuaki;
- Kaneko, Kengo;
- Matsuda, Kohji;
- Kishikawa, Hideki;
- Shichiri, Motoaki;
- Yoshimura, R;
- Araki, E;
- Ura, S;
- Todaka, M;
- Tsuruzoe, K;
- Furukawa, N;
- Motoshima, H;
- Yoshizato, K
Publication type:
journal article
Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells.
Published in:
1997
By:
- Matsuda, Kohji;
- Araki, Eiichi;
- Yoshimura, Ryohei;
- Tsuruzoe, Kaku;
- Furukawa, Noboru;
- Kaneko, Kengo;
- Motoshima, Hiroyuki;
- Yoshizato, Kazuaki;
- Kishikawa, Hideki;
- Shichiri, Motoaki;
- Matsuda, K;
- Araki, E;
- Yoshimura, R;
- Tsuruzoe, K;
- Furukawa, N;
- Kaneko, K;
- Motoshima, H;
- Yoshizato, K;
- Kishikawa, H;
- Shichiri, M
Publication type:
journal article
Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study
Published in:
Endocrine Journal, 2019, v. 66, n. 8, p. 745, doi. 10.1507/endocrj.ej19-0179
By:
- Seiya Shimoda;
- Wakana Sakamoto;
- Ayaka Hokamura;
- Yasuto Matsuo;
- Taiji Sekigami;
- Shinji Ichimori;
- Shinsuke Iwashita;
- Norio Ishii;
- Kae Otsu;
- Ryohei Yoshimura;
- Toshihiko Nishiyama;
- Masaji Sakaguchi;
- Kenro Nishida;
- Eiichi Araki
Publication type:
Article
Successful Treatment with Clonazepam and Pramipexole of a Patient with Sleep-Related Eating Disorder Associated with Restless Legs Syndrome: A Case Report.
Published in:
Case Reports in Medicine, 2012, p. 1, doi. 10.1155/2012/893681
By:
- Kobayashi, Nobuyuki;
- Yoshimura, Ryohei;
- Takano, Masahiro
Publication type:
Article

Found: 5

A 1-year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal-bolus insulin therapy (Kumamoto Insulin Degludec Observational study).

Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites result in impaired function at different steps of IRS-1 signaling.

Cell-specific regulation of IRS-1 gene expression: role of E box and C/EBP binding site in HepG2 cells and CHO cells.

Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study

Successful Treatment with Clonazepam and Pramipexole of a Patient with Sleep-Related Eating Disorder Associated with Restless Legs Syndrome: A Case Report.